Product Information
PROMETHAZINE 25 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0455 per EA under NDC 68001016203. Its NADAC has been published 163 times since Aug 23, 2023.
FDA first approved this application on Nov 18, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001016203
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROMETHAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040596FDA Approved
11/18/2005
TE Code
AB
On Market Since
1/13/2014
Pharmacological Classes
Price Statistics
The NADAC for PROMETHAZINE 25 MG TABLET has been published 163 times since Aug 23, 2023, and over the history we have for it it has declined 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0455 per EA |
|---|---|
| All-time high | $0.0517 (Mar 13, 2024) |
| All-time low | $0.0316 (Nov 20, 2024) |
| 52-week high | $0.0500 |
| 52-week low | $0.0454 |
| Median price | $0.0482 |
| Average price | $0.0468 |
| Largest weekly change | -35.2% (Nov 20, 2024) |
| Weeks tracked | 163 |
| Tracking since | Aug 23, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Promethazine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROMETHAZINE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROMETHAZINE 25 MG TABLET, manufactured by BluePoint Laboratories, is $0.0455 per EA (NDC 68001016203), effective Sep 30, 2026.
How has the price of PROMETHAZINE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROMETHAZINE 25 MG TABLET has declined 9.9%. It has been tracked across 163 weekly CMS publications since Aug 23, 2023.
What are the highest and lowest recorded NADAC prices for PROMETHAZINE 25 MG TABLET?
Since Aug 23, 2023, the NADAC for PROMETHAZINE 25 MG TABLET has ranged from a low of $0.0316 (Nov 20, 2024) to a high of $0.0517 (Mar 13, 2024), with a median of $0.0482 per EA.
Are there cheaper alternatives to PROMETHAZINE 25 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PROMETHAZINE 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PROMETHAZINE 25 MG TABLET?
PROMETHAZINE 25 MG TABLET (NDC 68001016203) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.